| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.507.643 | 1.855.903 | 2.187.519 | 1.599.998 | 1.361.266 | 926.170 | 975.332 | 1.634.936 | 1.278.039 | 1.387.487 |
| Total Income - EUR | 1.542.245 | 1.893.612 | 2.216.670 | 1.605.524 | 1.382.425 | 928.667 | 977.647 | 1.645.896 | 1.315.277 | 1.394.465 |
| Total Expenses - EUR | 1.753.928 | 2.151.559 | 2.435.184 | 1.765.778 | 1.549.516 | 986.761 | 1.234.605 | 1.482.487 | 1.312.754 | 1.358.798 |
| Gross Profit/Loss - EUR | -211.683 | -257.946 | -218.513 | -160.253 | -167.091 | -58.094 | -256.959 | 163.408 | 2.523 | 35.667 |
| Net Profit/Loss - EUR | -213.609 | -270.388 | -229.366 | -168.298 | -168.718 | -61.127 | -264.602 | 154.093 | -8.125 | 22.301 |
| Employees | 20 | 23 | 21 | 23 | 23 | 22 | 21 | 0 | 26 | 24 |
Check the financial reports for the company - 3S Pharmacological Consultation & Res. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.616.067 | 1.459.622 | 1.348.933 | 1.280.434 | 1.216.482 | 1.144.683 | 1.078.981 | 1.064.957 | 997.519 | 943.599 |
| Current Assets | 396.003 | 468.962 | 271.670 | 584.515 | 245.871 | 108.795 | 90.170 | 52.840 | 65.470 | 100.388 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 261.172 | 221.080 | 196.694 | 508.227 | 224.997 | 99.930 | 88.329 | 49.209 | 60.739 | 58.815 |
| Cash | 134.831 | 247.883 | 74.976 | 76.288 | 20.874 | 8.866 | 1.840 | 3.632 | 4.731 | 41.573 |
| Shareholders Funds | 811.493 | 394.534 | -26.217 | -320.046 | -593.477 | -678.172 | -927.735 | -851.228 | -882.040 | -858.887 |
| Social Capital | 1.125 | 49.886 | 49.042 | 48.142 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 645.117 | 1.534.050 | 807.947 | 784.532 | 830.236 | 966.844 | 825.629 | 805.987 | 1.741.168 | 1.911.164 |
| Income in Advance | 555.460 | 969.658 | 838.872 | 1.400.463 | 1.225.593 | 964.806 | 1.271.256 | 1.163.038 | 203.861 | 435 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - 3S Pharmacological Consultation & Res. Srl